Licaminlimab
- Generic Name
- Licaminlimab
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Oculis
- Target Recruit Count
- 122
- Registration Number
- NCT05896670
- Locations
- 🇺🇸
Oculis Investigative Site, Memphis, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath